tirzepatide bellaire tx Forte Flex-Dose 4 mL Injectable 15 mg/mL Tirzepatide | Omega Biologics

NCT06588296 (TOGETHER-PsA) (80) is a Phase 3b, randomized, multicentre, open-label study examining the efficacy and safety of ixekizumab compared to ixekizumab concomitantly administered with tirzepatide in overweight or obese adult patients with active PsA and at least one weight-related comorbidity

See the Difference for Yourself

Visible fading of dark spots and more even tone typically appears after 24 weeks of consistent daily use

Our team will work with you to determine the optimal treatment duration

The Pure Med Spa Difference: Your Core Message At Pure Med Spa , we understand that navigating the landscape of modern weight loss can be overwhelming

Published rates are starting points your NP confirms final pricing at consult